Lv11
18 积分 2024-01-22 加入
CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
2小时前
待确认
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence
3个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
4个月前
已完结
Immunotherapy for Malignant Glioma: Current Status and Future Directions
4个月前
已完结
Autophagy and EMT in cancer and metastasis: Who controls whom?
4个月前
已完结
Tumor-associated microenvironment, PD-L1 Expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: a comprehensive review with emphasis on the implications for neuropathologists
4个月前
已完结
RUNX1 and cancer
4个月前
已完结
Paraptosis: a non-classical paradigm of cell death for cancer therapy
6个月前
已完结
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
6个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
6个月前
已完结
皖公网安备34019202002308
